TSG Therapeutics
Latest round
- Series A
Last raised
- Dec 2022
Total raised
- $5.6M
Investors
- 6
About TSG Therapeutics
Based in Singapore, and founded in 2016, TSG Therapeutics operates as a preclinical-stage biopharmaceutical company that focuses on antiviral medicines to eliminate viral infectious diseases. The founder and the CEO of the company, Will Wonhyung Park, was the Managing Director and Head of the Strategic Investment Group at Deutsche Bank Group in Japan. Dr. Patricia Fast, the chief technology director, worked in National Institute of Allergy and Infectious Diseases. TSG Therapeutics has strategic cooperation with US National Institutes of Health, Vanderbilt University and other enterprises and universities. The technologies developed by the company are Viral Envelope Targeting and Membrane-Active Agents. The technology forms the basis of novel broad-spectrum antiviral solutions with the potential to counter unpredictable viral threats. TSG is developing drug candidates that attack the lipid envelope target, demonstrating potent antiviral results against diverse classes of viruses.
Who invested in TSG Therapeutics
6 investors across 1 round
See all investors in TSG Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Dec 28, 2022
Amount
$5.6M
Investors
Questions about TSG Therapeutics
Who invested in TSG Therapeutics?
TSG Therapeutics has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has TSG Therapeutics raised?
TSG Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did TSG Therapeutics last raise money?
TSG Therapeutics's most recent round on record is a Series A, in Dec 2022.
What does TSG Therapeutics do?
Based in Singapore, and founded in 2016, TSG Therapeutics operates as a preclinical-stage biopharmaceutical company that focuses on antiviral medicines to eliminate viral infectious diseases.
Where is TSG Therapeutics headquartered?
TSG Therapeutics is headquartered in Singapore.
Which VCs invest in companies like TSG Therapeutics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at TSG Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like TSG Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.